Timothy P. Hughes
South Australia Pathology(AU)Albert Einstein College of Medicine(US)Royal Adelaide Hospital(AU)Royal Adelaide Hospital(AU)Montefiore Medical Center(US)Royal Perth Hospital(AU)South Australian Health and Medical Research Institute(AU)Australasian Leukaemia and Lymphoma Group(AU)Wake Forest University(US)The University of Adelaide(AU)University of Adelaide(AU)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Eosinophilic Disorders and Syndromes, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research
Most-Cited Works
- → Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia(2003)3,549 cited
- → Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia(2006)3,464 cited
- → European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013(2013)1,979 cited
- → Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia(2010)1,669 cited
- → European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia(2020)1,470 cited
- → Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia(2014)1,367 cited